|
Pfizer/BioNTech |
Moderna |
J&J (Janssen) |
---|---|---|---|
Age restrictions |
16 or older |
18 or older |
18 or older |
Doses |
2 doses, 21 days apart |
2 doses, 28 days apart |
1 dose |
Efficacy-Overall* |
95% (7 days after second dose) |
94.1% (14 days after second dose) |
72% in US (28 days after dose) |
Efficacy in Preventing Severe Disease* |
90% |
100% |
87.6% in US |
Efficacy in Preventing Death* |
100% |
100% |
100% |
What about the variants? |
Developing booster |
Developing booster |
Adapting vaccine |
Vaccine Type |
mRNA |
mRNA |
Adenovirus vector |
Additional Information:
References